[{"address1": "5217 Winnebago Lane", "city": "Austin", "state": "TX", "zip": "78744", "country": "United States", "phone": "512 386 2900", "website": "https://www.xbiotech.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.", "fullTimeEmployees": 92, "auditRisk": 10, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 5, "overallRisk": 8, "governanceEpochDate": 1717200000, "maxAge": 86400, "priceHint": 2, "previousClose": 5.12, "open": 5.13, "dayLow": 5.01, "dayHigh": 5.3, "regularMarketPreviousClose": 5.12, "regularMarketOpen": 5.13, "regularMarketDayLow": 5.01, "regularMarketDayHigh": 5.3, "exDividendDate": 1626307200, "beta": 1.413, "forwardPE": 39.692307, "volume": 85186, "regularMarketVolume": 85186, "averageVolume": 93950, "averageVolume10days": 150400, "averageDailyVolume10Day": 150400, "bid": 4.99, "ask": 5.24, "bidSize": 100, "askSize": 100, "marketCap": 157160688, "fiftyTwoWeekLow": 3.51, "fiftyTwoWeekHigh": 9.96, "fiftyDayAverage": 7.8138, "twoHundredDayAverage": 5.714925, "currency": "USD", "enterpriseValue": -33878140, "floatShares": 19821457, "sharesOutstanding": 30457500, "sharesShort": 668481, "sharesShortPriorMonth": 670559, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0219, "heldPercentInsiders": 0.35137, "heldPercentInstitutions": 0.13268, "shortRatio": 9.14, "shortPercentOfFloat": 0.0375, "bookValue": 6.873, "priceToBook": 0.75076383, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -30743000, "trailingEps": -1.01, "forwardEps": 0.13, "enterpriseToEbitda": 0.858, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "XBIT", "underlyingSymbol": "XBIT", "shortName": "XBiotech Inc.", "longName": "XBiotech Inc.", "firstTradeDateEpochUtc": 1429104600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "fb07a30b-f4ae-35af-9fbb-83dba861caeb", "gmtOffSetMilliseconds": -14400000, "currentPrice": 5.16, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 201039008, "totalCashPerShare": 6.601, "ebitda": -39485000, "totalDebt": 10000000, "quickRatio": 11.963, "currentRatio": 12.027, "debtToEquity": 4.778, "returnOnAssets": -0.10963, "returnOnEquity": -0.1378, "freeCashflow": -16955250, "operatingCashflow": -21119000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]